Software maker Epocrates quietly performs facelift - Silicon Valley / San Jose Business Journal:

yfimuna.wordpress.com
The privately held San Mateo which provides clinical informatiojnand decision-support software to doctors and other bid farewell to Kirk Loevner, its formed chairman, president and CEO, in Decembe r and in early March name Rose Crane, a former pharmaceutical executive, as its new chiefr executive. Crane was most recentlh group chairman forthe over-the-counter and nutritionall businesses at pharmaceutical giant Johnson Johnson, and a former president of Bristol-Myers Squibb’s U.S. primary care according to Epocrates, which has annual sales of $65 millionj and employs more than200 people.
Also in earlty March, Epocrates promoted company co-founder Jeff Tangney from executive vice president of salesz and marketing to presidentand COO, and made a host of othedr changes in its senior executived ranks, spokeswoman Erica Morgenstern confirmed. Rick Van Hoesen, formerlyt its senior vice presiden of financeand CFO, was promoted to executiv e vice president of finance, retaining the CFO Paul Banta was promoted from seniorf vice president to executive vice president, general counsel and Robert Quinn moved from senior vice president of engineering to executiv vice president, retaining his chief technology officer Joe Kleine, formerly senior vice presidenty of health care sales, is now executivd vice president in charge of a new health care busineses unit.
Matt Campion, formerly a senior vice president ofmarket research, is now executivde vice president of the new markeft research unit. Michelle Snyder, previously vice president of marketing and is now senior vice president in charge of the new subscriberdbusiness unit. Loevner left in Decembedr for “various personal and professional Snyder said, and Crane, the new CEO, “is kind of Epocrates won’t discuss financials — late last year it canceled plans for a $75 milliob IPO — but is happy to talk aboutg its iPhone application for clinicians.
The app has been downloaded by 10 percentg of physicians nationwide in the past nine orabout 75,000 doctors, the company Epocrates boasts that its prescription drug and formularuy guide “continues to rank as the No. 1 free medicalo application downloaded in the AppleApp store,” saying doctors and other health care professionalxs use it to get information aboutg correct drug dosing, adverse reactions and interactions. clinical information is used by 600,000 healthh care professionals worldwide, including 225,000 U.S. doctors. Its goal is to increasw those numbers because Epocrates gains more sponsorship and subscriptioh revenue the more clinicians itsigns up.
As of late last Epocrates had raised morethan $86 million in fundint from VC firms including Sprout Group, Goldman Sachs, InterWest Partners, Draper Fisher Three Arch Partners and Bay City Capital.